Equities

Reuters first to report SoftBank leads latest Alto Pharmacy funding round

Reuters first to report SoftBank leads latest Alto Pharmacy funding round

Reuters was first to report that SoftBank’s Vision Fund 2 was leading a $250 million investment in Silicon Valley-based startup Alto Pharmacy. SoftBank’s Vision Fund II contributed a majority of the funding round. At one point, the fund considered investing as much as $300 million but eventually decided to limit its exposure. Other existing investors in Alto, including Greenoaks Capital and Jackson Square Ventures, also participated in the Series D round.